Key result
Long-term steroid therapy in patients with rheumatic disorders was associated with larger epicardial and pericardial fat areas compared to matched controls.
Why the study?
Does long-term steroid therapy increase epicardial and pericardial fat deposition in patients with rheumatic disorders?
Case-Control (n=122)
Single-blind
No
Does long-term steroid therapy increase epicardial and pericardial fat deposition in patients with rheumatic disorders?
Long-term steroid therapy in patients with rheumatic disorders is associated with a dose-dependent increase in epicardial and pericardial fat deposition, suggesting an elevated cardiovascular risk profile.
Answers are grounded in this paper and cite their sources.
May link long-term steroids to cardiac fat accumulation in rheumatic disease; hypothesis-generating and requires prospective confirmation.
BACKGROUND: Increased cardiac fat has been identified as a risk factor for coronary artery disease. Metabolic syndrome is associated with increased cardiac fat deposition. Steroids are known to imitate some effects of metabolic syndrome and are frequently used in patients with rheumatic disorders. Primary aim was to evaluate the impact of long-term steroid use on cardiac fat deposition in patients with rheumatic disorders. In addition, we sought to investigate if this effect might be dose-dependent. METHODS: Patients were enrolled as follows: (1) rheumatic disorder; and (2) long-term steroid therapy, and (3) underwent cardiovascular magnetic resonance (CMR) imaging. Patients were stratified in a high-dose (>7.5 mg prednisone equivalent/day for at least 6 months) and a low-dose steroid group (<7.5 mg prednisone equivalent/day) and compared to steroid-naïve controls without rheumatic disorders. RESULTS: 122 patients were included (n = 61 steroid patients, n = 61 controls). N = 36 were classified as high-dose, n = 25 as low-dose steroid group. Steroid patients showed larger epicardial 5.7 [3.5-9.1] cm(2) and pericardial 13.0 [6.1-26.8] cm(2) areas of fat than controls 4.2 [1.3-5.8] cm(2)/6.4 [1.6-15.4] cm(2), p < 0.001, p < 0.01, respectively. High-dose steroid patients had more epi- and pericardial fat both than controls: 7.2 [4.2-11.1] cm(2) vs. 4.4 [1.0-6.0] cm(2), p < 0.001; 18.6 [8.9-38.2] cm(2) vs. 10.7 [4.7-26.8] cm(2), p < 0.05, and patients in the low-dose steroid group (p < 0.01, p < 0.001, respectively). CONCLUSION: The present data suggest increased cardiac fat deposition in steroid-treated patients with rheumatic disorders. Furthermore, this accumulation of cardiac fat seems to be dose-dependent, pointing towards a cumulative effect of steroids.
No takes yet. Share an insight, caveat, or question.
Kitterer et al. (2015) conducted a case-control in Rheumatic disorders (n=122). Long-term steroid therapy vs. Steroid-naïve controls without rheumatic disorders was evaluated on Epicardial fat area (cm2) (p=<0.001). Long-term steroid therapy in patients with rheumatic disorders was associated with larger epicardial and pericardial fat areas compared to matched controls.
Synapse has enriched 10 related papers. Consider them for comparative context: